Publication | Open Access
PARP9 knockdown confers protection against chemoresistance and immune escape of breast cancer cells by blocking the PI3K/AKT pathway
10
Citations
40
References
2023
Year
PARP9 knockdown blocked the PI3K/AKT pathway to downregulate PD-L1, thus depressing chemoresistance and immune escape in breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1